Lateral Flow Immunochromatographic Assay for Detection of Antibodies Against a Recombinant Human Adenovirus Type 3 Hexon Fragment Using Gold Nanoparticles and Quantum Dots
Diagnostics · 21.08.2026 · 16 (16) · 2670
DOI: 10.3390/diagnostics16162670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 21.08.2026. Verfasst von Kanatbek Mukantayev und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunochemistry and Immunobiotechnology, National Center of Biotechnology, 13/5, Kurgalzhynskoye Road, Astana 010000, Kazakhstan. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.
Abstract (Originalsprache)
Background/Objectives: Human adenoviruses (HAdVs) are widely used as vectors for vaccines and gene therapy; however, pre-existing immunity can reduce their efficacy. Therefore, rapid and accessible serological methods are required to assess antibody levels against adenoviruses. Lateral flow immunochromatographic assay (LFIA) sensitivity depends on the label and antigen. In this study, we aimed to develop and evaluate LFIA systems based on gold nanoparticles (GNPs) and quantum dots (QDs) using a recombinant HAdV hexon protein.
Methods
A recombinant HAdV hexon protein fragment (rhHAdV, 35 kDa; amino acids A120-R316) was expressed in Escherichia coli and purified using Ni2+ affinity chromatography. Protein identity was confirmed using sodium dodecyl sulfate–polyacrylamide gel electrophoresis, Western blotting, and liquid chromatography–tandem mass spectrometry analyses. Two LFIA formats were developed using Protein G-conjugated GNPs (GNP-G) and QDs (QD-G). Agreement with the reference ELISA was evaluated using 90 human serum samples.
Results
The rhHAdV antigen demonstrated reactivity with anti-adenovirus-positive human sera in ELISA. Antibody detection was achieved at serum dilutions of up to 1:300 and 1:1000 for the GNP- and QD-based LFIA, respectively. The GNP-G and QD-G LFIA formats demonstrated positive percent agreements of 96.9% and 100%, respectively, while both assays showed a negative percent agreement of 98.2% compared with the reference ELISA.
Conclusions
The findings demonstrate the feasibility of a QD-based LFIA for qualitative detection of antibodies reactive with the recombinant HAdV-B3 hexon fragment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Immunochemistry and Immunobiotechnology, National Center of Biotechnology, 13/5, Kurgalzhynskoye Road, Astana 010000, Kazakhstan.
Förderung
- Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Mukantayev, K., Tursunov, K., Tokhtarova, L., & Abirbekov, B. (2026). Lateral Flow Immunochromatographic Assay for Detection of Antibodies Against a Recombinant Human Adenovirus Type 3 Hexon Fragment Using Gold Nanoparticles and Quantum Dots. Diagnostics, 16(16), 2670. https://doi.org/10.3390/diagnostics16162670
Vancouver
Mukantayev K, Tursunov K, Tokhtarova L, Abirbekov B. Lateral Flow Immunochromatographic Assay for Detection of Antibodies Against a Recombinant Human Adenovirus Type 3 Hexon Fragment Using Gold Nanoparticles and Quantum Dots. Diagnostics. 2026;16(16):2670. doi:10.3390/diagnostics16162670
BibTeX
@article{Mukantayev2026,
author = {Mukantayev, Kanatbek and Tursunov, Kanat and Tokhtarova, Laura and Abirbekov, Bisultan},
title = {Lateral Flow Immunochromatographic Assay for Detection of Antibodies Against a Recombinant Human Adenovirus Type 3 Hexon Fragment Using Gold Nanoparticles and Quantum Dots},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {16},
pages = {2670},
doi = {10.3390/diagnostics16162670}
}
EUVIMED